Population Pharmacokinetic Modeling of Guselkumab, a Human IgG1λ Monoclonal Antibody Targeting IL-23, in Patients with Moderate to Severe Plaque Psoriasis.
about
Population Pharmacokinetic Modeling of Guselkumab, a Human IgG1λ Monoclonal Antibody Targeting IL-23, in Patients with Moderate to Severe Plaque Psoriasis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Population Pharmacokinetic Mod ...... te to Severe Plaque Psoriasis.
@en
Population Pharmacokinetic Mod ...... te to Severe Plaque Psoriasis.
@nl
type
label
Population Pharmacokinetic Mod ...... te to Severe Plaque Psoriasis.
@en
Population Pharmacokinetic Mod ...... te to Severe Plaque Psoriasis.
@nl
prefLabel
Population Pharmacokinetic Mod ...... te to Severe Plaque Psoriasis.
@en
Population Pharmacokinetic Mod ...... te to Severe Plaque Psoriasis.
@nl
P2093
P2860
P356
P1476
Population Pharmacokinetic Mod ...... ate to Severe Plaque Psoriasis
@en
P2093
Amarnath Sharma
Bruce Randazzo
Chuanpu Hu
Honghui Zhou
Yasmine Wasfi
Zhenhua Xu
Zhenling Yao
P2860
P304
P356
10.1002/JCPH.1063
P50
P577
2018-01-17T00:00:00Z